Immunomedics (IMMU)

Immunomedics (IMMU) – FDA

Apr 13, 2021 02:39 PM FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial cancer
Oct 8, 2020 11:37 AM UPDATE: Immunomedics (IMMU) granted orphan drug status for treatment of malignant glioma
Sep 18, 2020 08:01 AM
Aug 17, 2020 08:03 AM
Jul 13, 2020 04:01 PM
Jul 6, 2020 07:56 AM
May 13, 2020 05:10 PM
Apr 22, 2020 11:49 AM
Apr 22, 2020 11:00 AM
Apr 22, 2020 11:00 AM
Apr 7, 2020 08:03 AM
Apr 6, 2020 08:06 AM
Apr 3, 2020 03:29 PM
Apr 1, 2020 01:08 PM
Dec 26, 2019 08:01 AM
Dec 3, 2019 08:01 AM
Sep 30, 2019 08:57 AM
Feb 11, 2019 05:17 PM
Feb 8, 2019 06:22 AM
Jan 18, 2019 09:15 AM
Jan 18, 2019 06:33 AM
Jan 17, 2019 06:07 PM
Dec 26, 2018 08:03 AM
Dec 6, 2018 08:14 AM
Jul 23, 2018 08:07 AM
Jul 18, 2018 08:03 AM
Jun 4, 2018 06:18 AM
Jun 1, 2018 08:07 AM
May 21, 2018 08:05 AM
May 16, 2018 05:05 PM
Apr 25, 2018 12:17 PM
Jan 11, 2018 08:01 AM
Dec 6, 2017 12:11 PM
Nov 13, 2017 04:43 PM
Sep 11, 2017 07:04 AM
Aug 21, 2017 08:04 AM
Jul 10, 2017 09:03 AM
May 5, 2017 08:01 AM
Apr 5, 2017 07:06 AM
Apr 4, 2017 08:02 AM
Mar 15, 2017 08:05 AM
Feb 17, 2017 12:04 PM
Feb 10, 2017 06:50 AM
Jan 18, 2017 09:02 AM
Jan 9, 2017 10:02 AM
Dec 27, 2016 07:03 AM
Dec 6, 2016 07:08 AM
Aug 18, 2016 07:03 AM
Jun 6, 2016 03:16 PM
Jun 6, 2016 09:00 AM